10 days ago
Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
What's happening
SignalsMonitor is following this as a health story. ScienceDaily Top News and ScienceDaily Health are the outlets attached to this story. The first report grouped here was at 7 Oct 2026, 12:13 UTC. 2 material updates are listed in the timeline. The headline in use is “Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Blocking a receptor called P2X7 significantly reduced inflammation in human brain tissue, revealing a potential new treatment strategy for neurological and psychiatric disorders. The discovery could help researchers repurpose existing drugs for conditions including traumatic brain injury, Alzheimer’s, Parkinson’s, depression, and schizophrenia.
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by ScienceDaily Health
Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
- Picked up by ScienceDaily Top News
Drug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
Same story, different outlets
2 headlinesEach line is that outlet's headline. The article stays on the publisher's site.
- ScienceDaily HealthDrug target could block brain inflammation linked to Alzheimer’s and Parkinson’s
- ScienceDaily Top NewsDrug target could block brain inflammation linked to Alzheimer’s and Parkinson’s